Dosidal · Switzerland

Sapropterin NOBEL, Tabletten zur Herstellung einer Lösung zum Einnehmen

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69374 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69374
atc: A16AX07
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2025-05-27
term: zugelassen
valid_until: 2030-05-26
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A16AX07
authorisation_number: 69374
form: TABLH
holder: NOBEL Pharma Schweiz AG
holder_partner_nr: 1102452
it_number: 07.99.0.
name: Sapropterin NOBEL, Tabletten zur Herstellung einer Lösung zum Einnehmen
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
u_vfbNyow0dgL5tL4t-lTkTAaex7YPtXBlFSRVU27AJ5bwASzG5-pDV7ojjlb7Qy3D6au26SbZDcbnyHIB1UcA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal